Compare · TMDX vs VAR
TMDX vs VAR
Side-by-side comparison of TransMedics Group Inc. (TMDX) and Varian Medical Systems, Inc. (VAR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TMDX and VAR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- TMDX carries a market cap of $2.50B.
- TMDX has hit the wire 5 times in the past 4 weeks while VAR has been quiet.
- TMDX has more recent analyst coverage (18 ratings vs 0 for VAR).
- Company
- TransMedics Group Inc.
- Varian Medical Systems, Inc.
- Price
- $72.31+1.53%
- -
- Market cap
- $2.50B
- -
- 1M return
- -6.89%
- -
- 1Y return
- -33.08%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NYSE
- IPO
- 2019
- n/a
- News (4w)
- 5
- 0
- Recent ratings
- 18
- 0
TransMedics Group Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.
Latest TMDX
- TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
- Officer Corcoran Nicholas was granted 11,727 shares, increasing direct ownership by 39% to 41,558 units (SEC Form 4)
- Chief Financial Officer Hernandez Gerardo was granted 17,246 shares, increasing direct ownership by 117% to 31,935 units (SEC Form 4)
- President & CEO Hassanein Waleed H was granted 49,669 shares, increasing direct ownership by 41% to 171,093 units (SEC Form 4)
- TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
- Director Gunderson Thomas J. exercised 19,285 shares at a strike of $2.21 and sold $722,377 worth of shares (9,624 units at $75.06), increasing direct ownership by 138% to 16,642 units (SEC Form 4) (for withholding tax)
- SEC Form 144 filed by TransMedics Group Inc.
- SEC Form SD filed by TransMedics Group Inc.
- Director Basile Edward M was granted 2,922 shares, increasing direct ownership by 102% to 5,788 units (SEC Form 4)
- Director Gunderson Thomas J. was granted 2,922 shares, increasing direct ownership by 72% to 6,981 units (SEC Form 4)
Latest VAR
- Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian
- Varian and Icon Group Partner to Extend Commitment to Global Cancer Care
- SEC Form 15-12B filed by Varian Medical Systems, Inc.
- SEC Form 4: Balser Jeffrey R. returned 2,824 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: BUTEL JEAN LUC returned 4,048 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: DUGAN REGINA E returned 12,396 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: ECKERT R ANDREW gifted 447 units of Common Stock and returned 13,826 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: BRUNER JUDY returned 6,779 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: ILLINGWORTH DAVID J returned 15,369 units of Common Stock to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: WILSON DOW R returned 39,231 units of Common Stock to the company and gifted 65,558 units of Common Stock, decreasing direct ownership by 100% to 0 units